KANJINTI trastuzumab 150 mg powder for injection vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1eaaf4647d7297db
Product Name: KANJINTI trastuzumab 150 mg powder for injection vial
Artg Id: 296881
Artg Name: KANJINTI trastuzumab 150 mg powder for injection vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2019-05-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b6a6abae2adb149ac16ee6fda3caaddb.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/283d8a5170cda3dcc9f07fd76253a052.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

1eaaf4647d7297db

Type

Standard